The Brain Donor Project announced today the addition of Bristol Myers Squibb (BMS) executive, Manan Shah, to its Board of Directors. Mr. Shah currently serves as Vice President, Head of Global Equity and Policy Partnerships with BMS. He also serves as an adjunct Assistant Professor of Public Health and Public Administration at Fairleigh Dickinson University, as well as an editor of the Public Health Open Journal.
“We are thrilled and honored to welcome Manan to our Board of Directors,” said Brain Donor Project Founder & CEO, Tish Hevel. “His expertise in health equity, public affairs, patient advocacy and public policy will be invaluable to our mission of raising awareness of the critical need of brain donation for neuroscience research.”
Shah is a leader in health equity and public affairs, having served in executive and global positions primarily in the pharmaceuticals industry, including roles with Novo Nordisk, Biogen, LEO Pharma and now Bristol Myers Squibb. He received his MBA from the University of Illinois Urbana-Champaign, Masters in Public Affairs and Politics from Rutgers University and Bachelor of Arts from American University. At the executive level, he received a Public Leadership Credential from the Harvard Kennedy School, and a certificate in Biopharmaceutical Pricing and Market Strategy from the University of Cambridge, and. Additionally, he serves on the Board of Directors of NewYorkBIO and is a mentor with Rutgers University’s Road to Industry Program (RTIP).